Maduck Sean has been actively involved in insider trading activity, exclusively focused on shares of Corcept Therapeutics Incorporated (CORT), as evidenced by SEC Form 4 filings. Over 40 transactions, Sean has demonstrated a clear selling bias, with total sell values amounting to $10,291,210.46 compared to total buy values of $928,741.38. Recent filings highlight this trend, with nine sell transactions occurring between August 2025 and March 2026. Notable sales include a $1,590,490 transaction on December 1, 2025, and a $1,479,816 sale on November 3, 2025. Smaller sales, such as $119,467.17 and $371,952.07 on August 1, 2025, further underscore the consistent divestment pattern.
The transactions also include acquisitions, though these are significantly smaller in scale. For example, purchases on December 1, 2025, and March 2, 2026, totaled $16,354.90 and $16,330.38, respectively. Additionally, filings indicate transactions coded as "F" (gift), "M" (exercise of derivative security), and "J" (other), though these often carry minimal or zero reported value. The data reveals a strategic focus on reducing holdings in CORT, with no recent buy activity recorded. This pattern suggests a deliberate shift away from equity in the company, though the reasons behind this trend remain undisclosed in the filings.
AI-assisted summary